{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:07:24Z","timestamp":1776881244820,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ryokufukai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mesenchymal stem cells (MSCs) provide potential treatments for peritoneal fibrosis. However, MSCs cultured in media containing serum bring risks of infection and other problems. In this study, we compared the effect of human MSCs in serum-free medium (SF-MSCs) on peritoneal fibrosis with that of MSCs cultured in medium containing 10% fetal bovine serum (10%MSCs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Peritoneal fibrosis was induced by intraperitoneally injecting 0.1% chlorhexidine gluconate (CG). SF-MSCs or 10%MSCs were intraperitoneally administered 30\u2009min after the CG injection. Ten days after the CG and MSC injections, we performed histological analyses and peritoneal equilibrium testing. In the in vitro experiments, we used transforming growth factor (TGF)-\u03b21-stimulated human peritoneal mesothelial cells incubated in conditioned medium from MSCs to examine whether the SF-MSCs showed enhanced ability to produce antifibrotic humoral factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Histological staining showed that the SF-MSCs significantly suppressed CG-induced cell accumulation and thickening compared with that of the 10%MSCs. Additionally, the SF-MSCs significantly inhibited mesenchymal cell expression, extracellular matrix protein deposition and inflammatory cell infiltration. Peritoneal equilibration testing showed that compared with administering 10%MSCs, administering SF-MSCs significantly reduced the functional impairments of the peritoneal membrane. The in vitro experiments showed that although the conditioned medium from MSCs suppressed TGF-\u03b21 signaling, the suppression did not significantly differ between the SF-MSCs and 10%MSCs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Serum-free culture conditions can enhance the antifibrotic abilities of MSCs by suppressing inflammation. Administering ex vivo expanded SF-MSCs may be a potential therapy for preventing peritoneal fibrotic progression.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13287-021-02273-1","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T07:02:52Z","timestamp":1616482972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis"],"prefix":"10.1186","volume":"12","author":[{"given":"Kohei","family":"Nagasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7838-1494","authenticated-orcid":false,"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ishiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyomasa","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehiro","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"issue":"9981","key":"2273_CR1","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(14)61601-9.","journal-title":"Lancet."},{"issue":"2","key":"2273_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1001\/archinternmed.2010.352","volume":"171","author":"R Mehrotra","year":"2011","unstructured":"Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2011;171(2):110\u20138. https:\/\/doi.org\/10.1001\/archinternmed.2010.352.","journal-title":"Arch Intern Med"},{"issue":"3","key":"2273_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230512","volume":"15","author":"S Elshahat","year":"2020","unstructured":"Elshahat S, Cockwell P, Maxwell AP, Griffin M, O'Brien T, O'Neill C. The impact of chronic kidney disease on developed countries from a health economics perspective: a systematic scoping review. PLoS One. 2020;15(3):e0230512. https:\/\/doi.org\/10.1371\/journal.pone.0230512.","journal-title":"PLoS One"},{"issue":"2","key":"2273_CR4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2273_CR5","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1681\/ASN.V13112787","volume":"13","author":"PJ Margetts","year":"2002","unstructured":"Margetts PJ, Churchill DN. Acquired ultrafiltration dysfunction in peritoneal dialysis patients. J Am Soc Nephrol. 2002;13(11):2787\u201394.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2273_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/089686089901900605","volume":"19","author":"MA Mateijsen","year":"1999","unstructured":"Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int. 1999;19(6):517\u201325. https:\/\/doi.org\/10.1177\/089686089901900605.","journal-title":"Perit Dial Int"},{"issue":"2","key":"2273_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2004060436","volume":"16","author":"PJ Margetts","year":"2005","unstructured":"Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, Kelly MM. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol. 2005;16(2):425\u201336. https:\/\/doi.org\/10.1681\/ASN.2004060436.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2273_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2013.81","volume":"84","author":"T Ueno","year":"2013","unstructured":"Ueno T, Nakashima A, Doi S, Kawamoto T, Honda K, Yokoyama Y, Doi T, Higashi Y, Yorioka N, Kato Y, Kohno N, Masaki T. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-\u03b21 signaling. Kidney Int. 2013;84(2):297\u2013307. https:\/\/doi.org\/10.1038\/ki.2013.81.","journal-title":"Kidney Int"},{"issue":"5","key":"2273_CR9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076\u201384. https:\/\/doi.org\/10.1002\/jcb.20886.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2273_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/mt.2011.211","volume":"20","author":"JP Darwin","year":"2012","unstructured":"Darwin JP, Joo YO. Mesenchymal stem\/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012;20(1):14\u201320. https:\/\/doi.org\/10.1038\/mt.2011.211.","journal-title":"Mol Ther"},{"issue":"6","key":"2273_CR11","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/stem.2598","volume":"35","author":"S He","year":"2017","unstructured":"He S, Gleason J, Fik-Rymarkiewicz E, DiFiglia A, Bharathan M, Morschauser A, Djuretic I, Xu Y, Krakovsky M, Jankovic V, Buensuceso C, Edinger J, Herzberg U, Hofgartner W, Hariri R. Human placenta-derived mesenchymal stromal-like cells enhance angiogenesis via T cell-dependent reprogramming of macrophage differentiation. Stem Cells. 2017;35(6):1603\u201313. https:\/\/doi.org\/10.1002\/stem.2598.","journal-title":"Stem Cells"},{"issue":"1","key":"2273_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger MF, Discher DE, P\u00e9ault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4(1):22. https:\/\/doi.org\/10.1038\/s41536-019-0083-6.","journal-title":"NPJ Regen Med"},{"issue":"9","key":"2273_CR13","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/j.1537-2995.2009.02226.x","volume":"49","author":"M P\u00e9rez-Ilzarbe","year":"2009","unstructured":"P\u00e9rez-Ilzarbe M, D\u00edez-Campelo M, Aranda P, Tabera S, Lopez T, del Ca\u00f1izo C, Merino J, Moreno C, Andreu EJ, Pr\u00f3sper F, P\u00e9rez-Sim\u00f3n JA. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion. 2009;49(9):1901\u201310. https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02226.x.","journal-title":"Transfusion."},{"issue":"2","key":"2273_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/art.23219","volume":"58","author":"A Nimura","year":"2008","unstructured":"Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum. 2008;58(2):501\u201310. https:\/\/doi.org\/10.1002\/art.23219.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2273_CR15","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3324\/haematol.11446","volume":"92","author":"M Sundin","year":"2007","unstructured":"Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica. 2007;92(9):1208\u201315. https:\/\/doi.org\/10.3324\/haematol.11446.","journal-title":"Haematologica."},{"issue":"3","key":"2273_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1182\/blood.V89.3.776","volume":"89","author":"TA Selvaggi","year":"1997","unstructured":"Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood. 1997;89(3):776\u20139. https:\/\/doi.org\/10.1182\/blood.V89.3.776.","journal-title":"Blood."},{"issue":"9","key":"2273_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1634\/stemcells.2005-0094","volume":"23","author":"A Shahdadfar","year":"2005","unstructured":"Shahdadfar A, Fr\u00f8nsdal K, Haug T, Reinholt FP, Brinchmann JE. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells. 2005;23(9):1357\u201366. https:\/\/doi.org\/10.1634\/stemcells.2005-0094.","journal-title":"Stem Cells"},{"issue":"1","key":"2273_CR18","doi-asserted-by":"publisher","first-page":"16570","DOI":"10.1038\/srep16570","volume":"5","author":"A Oikonomopoulos","year":"2015","unstructured":"Oikonomopoulos A, van Deen WK, Manansala AR, Lacey PN, Tomakili TA, Ziman A, Hommes DW. Optimization of human mesenchymal stem cell manufacturing: theeffects of animal\/xeno-free media. Sci Rep. 2015;5(1):16570. https:\/\/doi.org\/10.1038\/srep16570.","journal-title":"Sci Rep"},{"issue":"10","key":"2273_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.5966\/sctm.2012-0072","volume":"1","author":"LG Chase","year":"2012","unstructured":"Chase LG, Yang S, Zachar V, Yang Z, Lakshmipathy U, Bradford J, Boucher SE, Vemuri MC. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells. Stem Cells Transl Med. 2012;1(10):750\u20138. https:\/\/doi.org\/10.5966\/sctm.2012-0072.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"2273_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00441-013-1783-7","volume":"356","author":"S Gottipamula","year":"2014","unstructured":"Gottipamula S, Ashwin KM, Muttigi MS, Kannan S, Kolkundkar U, Seetharam RN. Isolation, expansion and characterization of bone marrow-derived mesenchymal stromal cells in serum-free conditions. Cell Tissue Res. 2014;356(1):1233\u20135. https:\/\/doi.org\/10.1007\/s00441-013-1783-7.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"2273_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jcyt.2013.11.004","volume":"16","author":"H Hemeda","year":"2014","unstructured":"Hemeda H, Giebel B, Wagner W. Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy. 2014;16(2):170\u201380. https:\/\/doi.org\/10.1016\/j.jcyt.2013.11.004.","journal-title":"Cytotherapy."},{"issue":"12","key":"2273_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/sctm.17-0284","volume":"7","author":"K Yoshida","year":"2018","unstructured":"Yoshida K, Nakashima A, Doi S, Ueno T, Okubo T, Kawano KI, Kanawa M, Kato Y, Higashi Y, Masaki T. Serum-free medium enhances the immunosuppressive and antifibrotic abilities of mesenchymal stem cells utilized in experimental renal fibrosis. Stem Cells Transl Med. 2018;7(12):893\u2013905. https:\/\/doi.org\/10.1002\/sctm.17-0284.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"2273_CR23","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/ki.1990.150","volume":"37","author":"E Stylianou","year":"1990","unstructured":"Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int. 1990;37(6):1563\u201370. https:\/\/doi.org\/10.1038\/ki.1990.150.","journal-title":"Kidney Int"},{"issue":"7","key":"2273_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/stem.3010","volume":"37","author":"R Barbara","year":"2019","unstructured":"Barbara R, Sudharshan E, Marco E, Emanuela S, Luciana P, Paolo K, et al. TNF-stimulated gene-6 is a key regulator in switching stemness and biological properties of mesenchymal stem cells. Stem Cells. 2019;37(7):973\u201387. https:\/\/doi.org\/10.1002\/stem.3010.","journal-title":"Stem Cells"},{"issue":"7","key":"2273_CR25","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2009070694","volume":"21","author":"O Devuyst","year":"2010","unstructured":"Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21(7):1077\u201385. https:\/\/doi.org\/10.1681\/ASN.2009070694.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2273_CR26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.imbio.2012.06.009","volume":"217","author":"JJ Worthington","year":"2012","unstructured":"Worthington JJ, Fenton TM, Czajkowska BI, Klementowicz JE, Travis MA. Regulation of TGF\u03b2 in the immune system: an emerging role for integrins and dendritic cells. Immunobiology. 2012;217(12):1259\u201365. https:\/\/doi.org\/10.1016\/j.imbio.2012.06.009.","journal-title":"Immunobiology."},{"issue":"3","key":"2273_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11684-017-0571-2","volume":"11","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Jiang N, Ni Z. Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis. Front Med. 2017;11(3):349\u201358. https:\/\/doi.org\/10.1007\/s11684-017-0571-2.","journal-title":"Front Med"},{"issue":"9","key":"2273_CR28","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1681\/ASN.2010111197","volume":"22","author":"J Loureiro","year":"2011","unstructured":"Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizca\u00edno P, P\u00e9rez-Lozano ML, Ruiz-Carpio V, Majano PL, Lamas S, Rodr\u00edguez-Pascual F, Borras-Cuesta F, Dotor J, L\u00f3pez-Cabrera M. Blocking TGF-\u03b21 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol. 2011;22(9):1682\u201395. https:\/\/doi.org\/10.1681\/ASN.2010111197.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2273_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54\u201363. https:\/\/doi.org\/10.1016\/j.stem.2009.05.003.","journal-title":"Cell Stem Cell"},{"issue":"24","key":"2273_CR30","doi-asserted-by":"publisher","first-page":"12627","DOI":"10.1074\/jbc.M116.720953","volume":"291","author":"DP Dyer","year":"2016","unstructured":"Dyer DP, Salanga CL, Johns SC, Valdambrini E, Fuster MM, Milner CM, Day AJ, Handel TM. The anti-inflammatory protein TSG-6 regulates chemokine function by inhibiting chemokine\/glycosaminoglycan interactions. J Biol Chem. 2016;291(24):12627\u201340. https:\/\/doi.org\/10.1074\/jbc.M116.720953.","journal-title":"J Biol Chem"},{"issue":"9","key":"2273_CR31","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340. https:\/\/doi.org\/10.1002\/jcp.26429.","journal-title":"J Cell Physiol"},{"issue":"2","key":"2273_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1006\/bbrc.2001.5777","volume":"288","author":"S Tsutsumi","year":"2001","unstructured":"Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun. 2001;288(2):413\u20139. https:\/\/doi.org\/10.1006\/bbrc.2001.5777.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"2273_CR33","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2215\/CJN.03470315","volume":"10","author":"R Mehrotra","year":"2015","unstructured":"Mehrotra R, Ravel V, Streja E, Kuttykrishnan S, Adams SV, Katz R, Molnar MZ, Kalantar-Zadeh K. Peritoneal equilibration test and patient outcomes. Clin J Am Soc Nephrol. 2015;10(11):1990\u20132001. https:\/\/doi.org\/10.2215\/CJN.03470315.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02273-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-021-02273-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02273-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:44:35Z","timestamp":1619743475000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02273-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2273"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02273-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of Hiroshima Graduate School of Biomedical Science (E-84) approved the HPMC isolation from human omentum, which was conducted in accordance with the Declaration of Helsinki. Each patient provided written informed consent. The Institutional Animal Care and Use Committee of Hiroshima University approved all animal experimental procedures (permit number: A19-127).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, is a collaborative research laboratory funded by TWOCELLS Company, Limited. Emeritus Prof. Kato is the vice president of TWOCELLS Company, Limited. All remaining authors have declared that no conflicts of interest exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}